Technology Overview and Perspectives from the DEFLECT III Randomized Trial - Alexandra Lansky, MD, FSCAI

↳ This is a section part of Moment: CRT 2016 Valve & Structural - Cerebral Embolic Protection Devices

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$9.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Technology Overview and Perspectives from the DEFLECT III Randomized Trial presented by Alexandra Lansky, MD, FSCAI at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$9.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists 
  • Structural Heart Specialists 
  • Interventional Fellows 
  • Cardiac Surgeons 
  • Imaging Specialists 
  • Radiologists

Session Name: Cerebral Embolic Protection Devices

Track: CRT Valve & Structural

Learning Objectives

  • Update in advances/best practice in Valve & Structural procedures

Other Components in this Moment

Overview
Neurocognition and Valve Disease: Incidence and Implications - Ronald Lazar, PhD, FAHA
Protection Devices for Stroke Prevention: Does the Data Support Routine Use? - Eberhard Grube, MD, FSCAI
Update on SENTINEL Trial Technology and Clinical Outcome - Susheel Kodali, MD, FSCAI
Technology Overview and Perspectives from the DEFLECT III Randomized Trial - Alexandra Lansky, MD, FSCAI
What Are the Options for Intervention of a Patient Who Has a Stroke after TAVR - Adnan Siddiqui, MD, PhD
Magnitude of Stroke Post-TAVR: Do We Need Cerebral Embolic Protection Devices? - Michael Mack, MD
Loading Simple Education